Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,219,244
-$1,077,445 QoQ
Shares Held
86,779
-24.2% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 87 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. LYEL ranks #246 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in LYEL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,219,244 | 86,779 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,296,689 | 114,491 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,975,656 | 96,675 | Shares | Defined | 2026-03-25 | |
| 2025-03-31 | $192,921 | 358,592 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $401,484 | 627,321 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,148,605 | 832,323 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $506,074 | 349,017 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $949,254 | 425,675 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,217,727 | 627,695 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $790,296 | 537,617 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,086,153 | 656,023 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,311,050 | 555,530 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,207,631 | 1,212,574 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,823,662 | 385,220 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,313,173 | 201,407 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $941,097 | 186,356 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $805,825 | 104,112 | Shares | Defined | 2022-02-17 | |
| 2021-06-30 | $3,281,032 | 202,034 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||